Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Head lice treatment comparison trial
ACTRN12607000564459Phase 4Completed
- Sponsor
- Ego Pharmaceuticals
- Start
- Nov 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of malathion and eucalyptus oil in pediculosis capitis (3 arms), sponsored by Ego Pharmaceuticals. Primary endpoint: Louse-free rate at Day 21 in the intention-to-treat population. Started Nov 2007; status: completed.
02
Drugs
malathioneucalyptus oil
03
Conditions
pediculosis capitis
Beyond the preview
Go deeper on ACTRN12607000564459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12607000564459.